Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Tris Pharma (Sales and Distribution Rights of Delsym)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A portfolio of sales and distribution rights. The asset covers United States store brand rights to sell and distribute Dextromehtorphan Polistirex Extended Release Suspension Cough Suppressant, the generic version of Reckitt Benckiser's Delsym.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare
Acquirer
Primary Office
  • 2031 US Highway 130
  • Monmouth Junction, NJ 08852
  • United States

Tris Pharma (Sales and Distribution Rights of Delsym) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Tris Pharma (Sales and Distribution Rights of Delsym)‘s full profile, request access.

Request full access to PitchBook

Tris Pharma (Sales and Distribution Rights of Delsym) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Tris Pharma (Sales and Distribution Rights of Delsym)‘s full profile, request access.

Request full access to PitchBook